ZA893244B - Agent for the prophylaxis of cardiac infarctions and the prevention of reinfarctions - Google Patents

Agent for the prophylaxis of cardiac infarctions and the prevention of reinfarctions

Info

Publication number
ZA893244B
ZA893244B ZA893244A ZA893244A ZA893244B ZA 893244 B ZA893244 B ZA 893244B ZA 893244 A ZA893244 A ZA 893244A ZA 893244 A ZA893244 A ZA 893244A ZA 893244 B ZA893244 B ZA 893244B
Authority
ZA
South Africa
Prior art keywords
agent
reinfarctions
prophylaxis
prevention
cardiac infarctions
Prior art date
Application number
ZA893244A
Other languages
English (en)
Inventor
Joachim Helbig
Helbig Joachim
Hans Georg Classen
Georg Classen Hans
Original Assignee
Verla Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verla Pharm filed Critical Verla Pharm
Publication of ZA893244B publication Critical patent/ZA893244B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA893244A 1988-05-02 1989-05-02 Agent for the prophylaxis of cardiac infarctions and the prevention of reinfarctions ZA893244B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3814856A DE3814856A1 (de) 1988-05-02 1988-05-02 Mittel zur prophylaxe des herzinfarkts und zur verhuetung des reinfarkts

Publications (1)

Publication Number Publication Date
ZA893244B true ZA893244B (en) 1990-01-31

Family

ID=6353393

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA893244A ZA893244B (en) 1988-05-02 1989-05-02 Agent for the prophylaxis of cardiac infarctions and the prevention of reinfarctions

Country Status (7)

Country Link
US (1) US5006516A (en:Method)
EP (1) EP0340540B1 (en:Method)
AT (1) ATE68973T1 (en:Method)
DE (2) DE3814856A1 (en:Method)
ES (1) ES2039735T3 (en:Method)
GR (1) GR3003081T3 (en:Method)
ZA (1) ZA893244B (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4335441A1 (de) * 1993-10-18 1995-04-20 Hans Dipl Chem Heide Mittel zur Gesundheitsvorsorge im Herz- Kreislaufsystem beim Menschen
US20040214884A1 (en) * 2003-04-28 2004-10-28 Hagen Brent P. Method for supplementing magnesium in an animal
US7041286B2 (en) * 2003-07-23 2006-05-09 Nerenberg Arnold P Composition for mitigating a pernicious thrombotic event
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
EP3684338A4 (en) 2017-09-22 2021-06-23 Otitopic Inc. DRY POWDER COMPOSITIONS WITH MAGNESIUM STEARATE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1809119C3 (de) * 1968-11-15 1973-12-20 Verla-Pharm Arzneimittelfabrik, Apotheker H.J.V.Ehrlich, 8132 Tutzing Infarktprophylaktikum
DE2228101C3 (de) * 1972-06-09 1979-07-05 Verla-Pharm. Arzneimittelfabrik, Apotheker H.J. V. Ehrlich, Gmbh & Co Kg, 8132 Tutzing Verfahren zur Gewinnung von Komplexverbindungen aus Aminodicarbonsäureionen, Magnesiumionen und Halogenidionen
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
DE3238118A1 (de) * 1982-10-14 1984-04-19 Verla-Pharm, Arzneimittelfabrik Apotheker H.J. v. Ehrlich GmbH & Co KG, 8132 Tutzing Verfahren zur herstellung von komplexverbindungen aus aminodicarbonsaeuren, zweiwertigen metallionen und halogenidionen
DE3340873A1 (de) * 1983-11-11 1985-05-23 ARTESAN GmbH Fabrik chemisch-pharmazeutischer Präparate, 3130 Lüchow Verwendung von magnesium-salicylat oder magnesium-acetylsalicylat

Also Published As

Publication number Publication date
US5006516A (en) 1991-04-09
ES2039735T3 (es) 1993-10-01
DE3814856A1 (de) 1989-11-16
EP0340540A3 (en) 1990-03-21
GR3003081T3 (en) 1993-02-17
EP0340540B1 (de) 1991-10-30
EP0340540A2 (de) 1989-11-08
DE58900410D1 (de) 1991-12-05
ATE68973T1 (de) 1991-11-15
DE3814856C2 (en:Method) 1992-02-20

Similar Documents

Publication Publication Date Title
DE58901934D1 (de) Verschlussanordnung fuer pharmazeutische flaschen.
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
CA2019974A1 (en) Treatment of inflammation
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
NZ221424A (en) Pharmaceutical compositions contaipyrimidines
EP0497258A3 (en) Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer
FI890176L (fi) Preventivmedel:mikrokondom.
GB2223107B (en) Non-contact tonometer
ZA879173B (en) Therapeutic agents
IL75852A0 (en) Combination product composed of pyrimido-pyrimidines and o-acetylsalicylic acid or its pharmacologically tolerated salts,and its use
AU1971988A (en) Pharmaceutical compositions for the treatment of uraemia
EP0340540A3 (en) Agent for the prophylaxis of a heart infarct and for the prevention of another infarct
EP0349143A3 (en) Use of phytic acid or its salts for the prevention or treatment of hepatic diseases
USD354840S (en) Elastic cuff safe for arm or leg use
ATE216586T1 (de) Hirudin enthaltende arzneimittel
RU93041779A (ru) Средство для лечения иммунодефицитных состояний
IL81549A0 (en) Pharmaceutical compositions containing glycerophosphoryl-o-serine or a salt thereof,certain such novel salts and their preparation
ZA93694B (en) Pharmaceutical treatments.
GB8813032D0 (en) Antiviral pharmaceutical composition
GR3005531T3 (en:Method)
GB8922722D0 (en) Rotary forged curved side flange for five piece rims
CA2057456A1 (en) Anti depression pharmaceutical
EP0419354A3 (en) Use of a complex of inosine with a n,n-dialkylamino-alkanol or one of its salts with a pharmacologically acceptable acid for the treatment of certain helmintic infections
GR3006256T3 (en:Method)
郭映春 et al. A CASE STUDIES SWALLOWING-INDUCED CARDIAC ARRHYTHMIA